New Vaccines | Vibepedia

New vaccines represent a significant advancement in the field of immunology, leveraging innovative technologies such as mRNA, viral vectors, and nanoparticle-based platforms to combat emerging and re-emerging infectious diseases. With the global vaccine market projected to reach $64 billion by 2027, growing at a CAGR of 10.5%, the development of new vaccines is crucial for preventing and controlling outbreaks. According to the World Health Organization (WHO), vaccination has saved millions of lives, and new vaccines are being developed to address the ongoing challenges posed by diseases such as COVID-19, Ebola, and influenza. The latest advancements in vaccine technology, including the use of artificial intelligence and machine learning, are enabling the rapid development and deployment of effective vaccines, with companies like [[moderna-therapeutics|Moderna Therapeutics]] and [[pfizer|Pfizer]] at the forefront of this innovation. As of 2023, there are over 140 COVID-19 vaccines in development, with several already approved for emergency use, demonstrating the unprecedented pace of progress in this field.